Blood advances · 2026 May 12
Belantamab mafodotin, carfilzomib, lenalidomide, and dexamethasone for relapsed or refractory multiple myeloma.
Journal Article · Clinical Trial, Phase II · Clinical Trial, Phase I
Open attributed record →Attributed PubMed bibliography
25 selected PubMed bibliographic records connected to the reviewed Carfilzomib identity. Identity matching connects these records; it does not summarize their findings or imply safety, effectiveness, or scientific agreement.
25 selected records.
6 attributed years.
17 distinct venues.
Publication chronology
Blood advances · 2026 May 12
Journal Article · Clinical Trial, Phase II · Clinical Trial, Phase I
Open attributed record →Nature medicine · 2026 04 06
Journal Article · Randomized Controlled Trial · Clinical Trial, Phase III
Open attributed record →International journal of hematology · 2025 10 24
Journal Article · Clinical Trial, Phase II
Open attributed record →HemaSphere · 2025 07 16
Journal Article · Review
Open attributed record →Leukemia & lymphoma · 2025 05 21
Journal Article · Clinical Trial, Phase II · Multicenter Study · Clinical Trial, Phase I
Open attributed record →Frontiers in pharmacology · 2025 03 27
Journal Article · Review
Open attributed record →Blood advances · 2025 Feb 11
Journal Article · Clinical Trial, Phase II
Open attributed record →European journal of haematology · 2024 12 05
Clinical Trial, Phase II · Journal Article · Multicenter Study
Open attributed record →British journal of haematology · 2024 06 28
Journal Article · Clinical Trial, Phase II · Multicenter Study
Open attributed record →Blood cancer journal · 2024 05 29
Journal Article · Clinical Trial, Phase II · Research Support, Non-U.S. Gov't
Open attributed record →Polish archives of internal medicine · 2024 05 14
Journal Article · Clinical Trial, Phase III · Research Support, Non-U.S. Gov't
Open attributed record →Haematologica · 2024 02 01
Clinical Trial · Journal Article · Research Support, Non-U.S. Gov't
Open attributed record →Blood advances · 2023 Oct 10
Clinical Trial, Phase II · Clinical Trial, Phase I · Journal Article · Research Support, Non-U.S. Gov't
Open attributed record →The Lancet. Oncology · 2023 09 14
Journal Article · Multicenter Study · Clinical Trial, Phase II · Research Support, Non-U.S. Gov't
Open attributed record →British journal of haematology · 2023 09 10
Clinical Trial, Phase III · Randomized Controlled Trial · Journal Article · Research Support, Non-U.S. Gov't
Open attributed record →Targeted oncology · 2023 08 26
Clinical Trial, Phase I · Journal Article · Research Support, Non-U.S. Gov't
Open attributed record →Clinical lymphoma, myeloma & leukemia · 2023 07 03
Clinical Trial, Phase III · Journal Article · Randomized Controlled Trial · Research Support, Non-U.S. Gov't
Open attributed record →Blood advances · 2023 Apr 11
Clinical Trial, Phase I · Journal Article
Open attributed record →The Lancet. Oncology · 2023 01 12
Randomized Controlled Trial · Multicenter Study · Clinical Trial, Phase III · Journal Article · Research Support, Non-U.S. Gov't
Open attributed record →The Lancet. Haematology · 2022 12 15
Clinical Trial, Phase II · Equivalence Trial · Journal Article · Randomized Controlled Trial
Open attributed record →Japanese journal of clinical oncology · 2022 Dec 05
Clinical Trial, Phase III · Journal Article · Randomized Controlled Trial · Research Support, Non-U.S. Gov't
Open attributed record →Transplantation and cellular therapy · 2022 11 11
Randomized Controlled Trial · Clinical Trial, Phase III · Journal Article · Research Support, Non-U.S. Gov't
Open attributed record →Haematologica · 2022 06 01
Clinical Trial, Phase III · Journal Article · Research Support, Non-U.S. Gov't
Open attributed record →International journal of hematology · 2022 05 17
Journal Article · Randomized Controlled Trial
Open attributed record →The Lancet. Oncology · 2021 11 11
Clinical Trial, Phase II · Journal Article · Multicenter Study · Randomized Controlled Trial · Research Support, Non-U.S. Gov't
Open attributed record →